Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.

Loi S, Drubay D, Adams S, Pruneri G, Francis PA, Lacroix-Triki M, Joensuu H, Dieci MV, Badve S, Demaria S, Gray R, Munzone E, Lemonnier J, Sotiriou C, Piccart MJ, Kellokumpu-Lehtinen PL, Vingiani A, Gray K, Andre F, Denkert C, Salgado R, Michiels S.

J Clin Oncol. 2019 Mar 1;37(7):559-569. doi: 10.1200/JCO.18.01010. Epub 2019 Jan 16.

PMID:
30650045
2.

A benchmark study of scoring methods for non-coding mutations.

Drubay D, Gautheret D, Michiels S.

Bioinformatics. 2018 May 15;34(10):1635-1641. doi: 10.1093/bioinformatics/bty008.

PMID:
29340599
3.

Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study.

Angevin E, Cassier PA, Italiano A, Gonçalves A, Gazzah A, Terret C, Toulmonde M, Gravis G, Varga A, Parlavecchio C, Paci A, Poinsignon V, Soria JC, Drubay D, Hollebecque A.

Eur J Cancer. 2017 Sep;83:194-202. doi: 10.1016/j.ejca.2017.06.036. Epub 2017 Jul 24.

PMID:
28750271
4.

Dose-Finding Methods: Moving Away from the 3 + 3 to Include Richer Outcomes.

Paoletti X, Drubay D, Collette L.

Clin Cancer Res. 2017 Aug 1;23(15):3977-3979. doi: 10.1158/1078-0432.CCR-17-1306. Epub 2017 Jun 19.

5.

A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events.

Li J, Poursat MA, Drubay D, Motz A, Saci Z, Morillon A, Michiels S, Gautheret D.

PLoS Comput Biol. 2015 Nov 20;11(11):e1004583. doi: 10.1371/journal.pcbi.1004583. eCollection 2015 Nov.

6.

Mining the coding and non-coding genome for cancer drivers.

Li J, Drubay D, Michiels S, Gautheret D.

Cancer Lett. 2015 Dec 28;369(2):307-15. doi: 10.1016/j.canlet.2015.09.015. Epub 2015 Oct 1. Review.

PMID:
26433158
7.

Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: A study based on patient specific artery segments dose calculation.

Moignier A, Broggio D, Derreumaux S, Beaudré A, Girinsky T, Paul JF, Drubay D, Lefkopoulos D, Franck D, Aubert B, Deutsch E, Bourhis J.

Radiother Oncol. 2015 Dec;117(3):467-72. doi: 10.1016/j.radonc.2015.07.043. Epub 2015 Aug 12.

PMID:
26277431
8.

Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study.

Drubay D, Caër-Lorho S, Laroche P, Laurier D, Rage E.

Radiat Res. 2015 May;183(5):550-62. doi: 10.1667/RR13834.1. Epub 2015 Mar 25.

PMID:
25807316
9.

Mortality analyses in the updated French cohort of uranium miners (1946-2007).

Rage E, Caër-Lorho S, Drubay D, Ancelet S, Laroche P, Laurier D.

Int Arch Occup Environ Health. 2015 Aug;88(6):717-30. doi: 10.1007/s00420-014-0998-6. Epub 2014 Nov 20.

PMID:
25410273
10.

Kidney cancer mortality and ionizing radiation among French and German uranium miners.

Drubay D, Ancelet S, Acker A, Kreuzer M, Laurier D, Rage E.

Radiat Environ Biophys. 2014 Aug;53(3):505-13. doi: 10.1007/s00411-014-0547-4. Epub 2014 May 24.

PMID:
24858911

Supplemental Content

Loading ...
Support Center